Italia markets closed

ILMN Jan 2025 100.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
8,60-4,40 (-33,85%)
In data: 01:24PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente13,00
Aperto9,20
Denaro7,50
Domanda9,40
Prezzo d'esercizio100,00
Scadenza2025-01-17
Min-Max giorno8,60 - 9,20
Contratto - Min-MaxN/D
Volume17
Open Interest2,47k
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera